- Aug 2, 2022
-
FUJIFILM Sonosite is now the Exclusive Ultrasound Sponsor of The Resuscitative TEE Workshop
- Jul 26, 2022
- FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory
- Jul 14, 2022
- Fujifilm Announces Sale Agreement for its Greenwood, South Carolina Campus with an Affiliate of Phoenix Investors
- Jul 13, 2022
- Fujifilm Announces $350 Million Investment in its U.S. Electronic Materials Business by Early 2024
- Jul 7, 2022
- Fujifilm Launches FDR Cross, the World’s First Two-in-one Fluoroscopy and Digital Radiography System
- Jul 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Jun 30, 2022
- Richard Fabian Named Chief Executive Officer of FUJIFILM Sonosite
- Jun 29, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Jun 29, 2022
-
Fujifilm Celebrates Four Recent Recipients of Fujifilm Fellowship at
Harvard Medical School
- Jun 22, 2022
- FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
- Jun 16, 2022
- FUJIFILM Imaging Colorants, Inc. Celebrates Opening of State-of-the-Art New Aqueous Ink Inkjet Dispersion Manufacturing Facility in Delaware
- Jun 15, 2022
- Fujifilm Introduces the New INSTAX MINI LINK™ 2 Smartphone Printer
- Jun 14, 2022
- Fujifilm Life Sciences Showcases its Comprehensive Solutions to Support Advanced Therapies at BIO2022
- Jun 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- May 31, 2022
- Fujifilm Unveils Latest Development Roadmap for Interchangeable Lenses in X Series of Mirrorless Digital Cameras
- May 31, 2022
- Fujifilm Introduces FUJINON XF150-600mmF5.6-8 R LM OIS WR Lens
- May 31, 2022
- Fujifilm Introduces FUJINON XF18-120mmF4 LM PZ WR Lens
- May 31, 2022
- Fujifilm Introduces X-H2S Mirrorless Digital Camera
- May 31, 2022
- Fujifilm Begins U.S. Clinical Phase 2a Study of FF-10832 in Combination with KEYTRUDA® (pembrolizumab, Merck & Co., Inc., Rahway, N.J., U.S.A.) for Patients with Advanced Solid Tumors
- May 24, 2022
-
FUJIFILM Cellular Dynamics Launches Parkinson’s Disease iCell DopaNeurons featuring LRRK2 and GBA Mutations